Pre-pandemic group | Post-pandemic group | P-value | |
---|---|---|---|
Cases | 289 | 91 | |
Age | 0.373 | ||
< 60years | 252(87.2%%) | 76(83.52%) | |
> 60years | 37(12.8%) | 15(16.48%) | |
Gender | 0.288 | ||
Male | 180(62.28%) | 51(56.04%) | |
Female | 109(37.72%) | 40(43.96%) | |
Appendiceal fecalith | 0.194 | ||
Yes | 185(64.01%) | 65(71.43%) | |
No | 104(35.99%) | 26(28.57%) | |
Fever(>37.5 °C) | 0.259 | ||
Yes | 29(10.03%) | 13(14.29%) | |
No | 260(89.97%) | 78(85.71%) | |
Jaundice | 0.505 | ||
Yes | 129(44.64%) | 37(40.66%) | |
No | 160(55.36%) | 54(59.34%) | |
Anesthesia | 0.005* | ||
Lumbar anesthesia | 84(29.07%) | 41(45.25%) | |
General anesthesia | 205(70.93%) | 50(54.95%) | |
Surgery | |||
OA | 89(30.8%) | 49(53.85%) | 0.007* |
LA | 200(69.2) | 42(46.15%) | |
Conversion to open surgery | 1 | 0 | |
Length of onset before presenting to ED(h) | 20.91 ± 17.06 | 21.01 ± 26.45 | 0.972 |
White cell count(10 9 /L) | 14.14 ± 3.88 | 15.08 ± 3.51 | 0.096 |
Pathology | 0.016* | ||
Gangrene | 79(27.34%) | 37(40.66%) | |
Non-gangrene | 210(72.66%) | 54(59.34%) | |
Complications | 0.037* | ||
Yes | 12(4.15%) | 9(9.89%) | |
No | 277(95.85%) | 82(90.11%) | |
Length of stay(days) | 4.73 | 5.14 | 0.467 |